NCT02173665View on ClinicalTrials.gov

Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Single Rising Oral Doses of BI 1356 BS Administered to Healthy Male Subjects

PHASE1CompletedINTERVENTIONAL
Enrollment

64

Participants

Timeline

Start Date

October 31, 2004

Primary Completion Date

December 31, 2004

Conditions
Healthy
Interventions
DRUG

BI 1356 BS - Powder in bottle (PIB)

DRUG

BI 1356 BS - Tablet

DRUG

Placebo

Sponsors
All Listed Sponsors
lead

Boehringer Ingelheim

INDUSTRY